Detail of outcome
The Medicines and Healthcare products Regulatory Agency (MHRA) has agreed to reclassify Pirinase Hayfever Relief for Adults 0.05% Nasal Spray (fluticasone propionate) from a pharmacy (P) medicine to a general sales list medicine (GSL).
See the public assessment report for more information.
Detail of feedback received
A total of 11 responses were received, of which 4 were in favour, 4 were not in favour, and 3 were responses with no comment. 1 of the responses was confidential.
This consultation ran from to
This consultation (ARM83) welcomes views on proposals to classify Pirinase Hayfever Relief for Adults 0.05% Nasal Spray as a general sales list (GSL) product in the UK.
This consultation was held on another website
Consultation ARM 83 seeks your views on the Pharmacy (P) to General Sales List (GSL) reclassification of Pirinase Hayfever Relief for Adults 0.05% Nasal Spray (fluticasone propionate).